Bimatoprost, also known as Latisse or Lumigan, belongs to a group of drugs called prostamides, which are synthetic structural analogs of prostaglandin. Bimatoprost, marketed by Allergan, is administered in both the ophthalmic solution and implant form. It has the ability to reduce ocular hypotension, proving effective in conditions such as ocular hypertensio...
Bimatoprost is used for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
These patients must be intolerant to other intraocular pressure lowering medications or inadequately responsive to other treatments.
Bimatoprost is also indicated to treat eyelash hypotrichosis.
MedStar Washington Hospital Center, Washington, District of Columbia, United States
Medical University of South Carolina, Charleston, South Carolina, United States
Hospital, Tallinn, Estonia
Clinica de Ojos Orillac - Calvo, Panama City, Panama
J&S Studies Inc., College Station, Texas, United States
E&R Research Foundation, Lynchburg, Virginia, United States
DermResearch, LLC, Austin, Texas, United States
Sall Medical Research Center, Artesia, California, United States
Total Eye Care, Memphis, Tennessee, United States
Eye Research Foundation, Newport Beach, California, United States
Bascom Palmer Eye Institute - University of Miami, Miami, Florida, United States
Vold Vision, Fayetteville, Arkansas, United States
Total Eye Care, Memphis, Tennessee, United States
University of Eye Specialists, Maryville, Tennessee, United States
Universitaets-augenklinik, Magdeburg, Germany
Department of Ophthalmology, University of Thessaly, University Hos- pital of Larissa, Larissa, Greece
A.O. San Paolo, Milan, Lombardy, Italy
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.